MedPath

Near-Continuous, Noninvasive Blood Pressure Monitoring to Improve Outcomes in Pediatric Transport

Not Applicable
Terminated
Conditions
Pediatric Patients With SIRS (Systemic Inflammatory Response Syndrome)
Interventions
Device: Standard of care blood pressure monitoring
Device: Continuous blood pressure monitoring using (Dinamap) standard oscillometric blood pressure device
Registration Number
NCT00279591
Lead Sponsor
University of Arkansas
Brief Summary

A randomized controlled trial compared the clinical outcomes of transported pediatric patients monitored with an oscillometric blood pressure device versus those monitored with a near-continuous, noninvasive blood pressure.

Detailed Description

94 transported patients were randomized to a control arm, monitored with a standard oscillometric blood pressure device (Dinamap), or an experimental arm, monitored with a near-continuous, noninvasive blood pressure device (Vasotrac).

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
94
Inclusion Criteria
  1. Pediatric patients transported by Angel One to Arkansas Children's Hospital.

  2. Age Group: 1 year - 17 years AND

  3. Patients at risk of developing SIRS (Systemic Inflammatory Response Syndrome), according to the criteria below.

    i. The presence of at least two of the following four criteria (one of which must be abnormal temperature or leukocyte count): A. Core temperature of >38.5 C or <36 C. B. Tachycardia, defined as mean heart rate >95th percentile for age in absence of external stimulus, chronic drugs, or painful stimuli.

    C. Mean respiratory rate >95th percentile for age, or >10% immature neutrophils.

    OR

  4. Patients with moderate or severe head trauma, at risk of developing secondary ischemic brain injury, according to the criteria below.

    i. Glasgow Coma scale <15 with one or more of the following: A. Mass lesion or cerebral edema on CT or MRI scan. B. Post-Traumatic Seizure. C. Multiple Trauma. D. Focal Neurologic Signs. E. Intubation for control of suspected intracranial hypertension.

Exclusion Criteria
  1. Wrist circumference less than 11cm (minimum size for the Vasotrac device).
  2. Contractures of the wrists, not allowing correct placement of the Vasotrac device.
  3. Hematoma(s) located on both wrists from recent redial (<24hr) artery puncture.
  4. Patients likely to proceed to brain death per assessment of the referring physician.
  5. Patients being treated for malignant hypertension.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard of care blood pressure monitoringStandard of care blood pressure monitoringPatients received the normal standard of care for blood pressure monitoring during the course of the med flight to the hospital.
Continuous Blood Pressure MonitoringContinuous blood pressure monitoring using (Dinamap) standard oscillometric blood pressure devicePatients received continuous blood pressure monitoring the entire time they were in med flight to the hospital.
Primary Outcome Measures
NameTimeMethod
The Difference in Hospital Length of Stay Between Those Who Received Continuous Blood Pressure Monitoring and Those Who Received Standard of CareUp to two weeks

This is the total number of participants analyzed for the intervention group and the total number of participants analyzed for the control group and the total number of days that each group was analyzed overall.

Secondary Outcome Measures
NameTimeMethod
Intensive Care Unit (ICU) Length of StayUp to two weeks
Mean Daily Score Using the Therapeutic Intervention Scoring System (TISS-28) Scale.Up to two weeks

The Therapeutic Intervention Scoring System (TISS-28) is an illness severity score for the ICU. The TISS score can range from zero up to 78. The higher the score is, the more severe the illness. The TISS-28 scale measures the severity of a patient's illness.

Amount of Intravenous Fluid ResuscitationAt start of inter-facility transport, then every 15 minutes until arrival.
Total Number of Organ Failure Days (Multiple Organ Dysfunction) in the Intensive Care Unit (ICU)for the Control Group and Total Number of Organ Failure Days for the Intervention Group. Multiple Organ Dysfunction is Defined as Multiple Organ Failure.Up to two weeks

Total number of organ failure days is for each group as a whole.

Trial Locations

Locations (1)

Arkansas Children's Hospital

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath